PORTLAND, Oregon and PUNE, India, November 15, 2017 /PRNewswire/ --
According to a new report published by Allied Market Research, titled, "Organ-On-Chip Market by Type (Heart-on-Chip, Human-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Liver-on-Chip, and Lung-on-Chip): Global Opportunity Analysis and Industry Forecast, 2017-2023," the global organ-on-chip market was valued at $5 million in 2016, and is projected to reach at $170 million by 2023, growing at a CAGR of 63.2% from 2017 to 2023. Heart-on-chip segment is anticipated to witness the highest growth rate during the forecast period.
Do Enquiry for Sample Report@ https://www.alliedmarketresearch.com/request-sample/2555
North America was the highest revenue contributor in the global market in 2016, as advancements in cell biology, microfabrication, and microfluidics have led to the development of OOCs. In addition, rise in demand for lung- and kidney-based organ culture devices is expected to boost the market growth. Asia-Pacific is anticipated to witness a significant growth rate during the forecast period, owing to increase in research activities.
In 2016, the lung-on-chip segment accounted for the highest share in the market, while the heart-on-chip segment is anticipated to witness the highest growth rate from 2017 to 2023, owing to increase in applications of organ-on-chip devices for the cure of several cardiac diseases such as heart failures.
Do Enquiry before purchasing Report@ https://www.alliedmarketresearch.com/purchase-enquiry/2555
The key players profiled in the study are Emulate, Inc., AxoSim Technologies LLC, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, Inc., Insphero AG, Mimetas B.V, Nortis Inc., Organovo Holdings, Inc., and Tara Biosystems. These players have adopted various competitive strategies such as geographical expansions, mergers & acquisitions, new product launches, and partnerships & collaborations to strengthen their foothold in the market.
Key Findings of the Organ-On-Chip Market:
- Heart-on-chip segment is projected to witness the highest growth rate of 64.1%.
- North America generated the highest share of $60 million, in terms of revenue, in 2016.
- Asia-Pacific generated the highest growth rate of 65.2% during the forecast period.
- Lung-on-chip segment generated highest market share of 21% in 2016.
Ask for discount before buying@ https://www.alliedmarketresearch.com/get-discount/2555
Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free : +1-800-792-5285
UK : + 44-845-528-1300
Hong Kong : + 852-301-84916
India (Pune) : +91 20 66346060
Fax : +1⟨855⟩550-5975
SOURCE Allied Market Research